Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer

Published:2015-09-25 Issue:12 Volume:10 Page:2687-2696
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Terai Hideki¹,Tan Li²³,Beauchamp Ellen M.¹,Hatcher John M.²³,Liu Qingsong²³,Meyerson Matthew¹⁴⁵,Gray Nathanael S.²³,Hammerman Peter S.¹⁵

Affiliation:

1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States

2. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States

3. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States

4. Department of Pathology, Brigham and Women’s Hospital, Boston Massachusetts, United States

5. Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acschembio.5b00655

Reference50 articles.

1. Quality Indicators in Cancer Care: Development and Implementation for Improved Health Outcomes in Non–Small-Cell Lung Cancer

2. Histologic Considerations for Individualized Systemic Therapy Approaches for the Management of Non-small Cell Lung Cancer

3. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

4. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

5. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of cell mechanics and migration on DDR2-expressing neuroblastoma cell line;2024-08-16

2. Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR);ChemistrySelect;2024-08-06

3. Research progress of DDR1 inhibitors in the treatment of multiple human diseases;European Journal of Medicinal Chemistry;2024-03

4. Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis;The Journal of Pathology;2024-02-09

5. DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC;Cellular and Molecular Gastroenterology and Hepatology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3